Chest ACCP Career Connection
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, S.
Right arrow Articles by Gracey, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Peters, S.
Right arrow Articles by Gracey, D.

Chest, Vol 94, 99-102, Copyright © 1988 by American College of Chest Physicians

ARTICLES

Outcome of respiratory failure in hematologic malignancy

SG Peters, JA Meadows 3d and DR Gracey
Division of Thoracic Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.

We reviewed records of patients with hematologic malignancy requiring mechanical ventilation (MV) from 1976 to 1985 (excluding postoperative MV less than 48 hours). There were 119 episodes in 116 patients. In- hospital mortality was 82 percent. Of 21 (18 percent) episodes survived, median duration of survival was 12 months. Survivors did not differ from nonsurvivors in age, leukocyte count, or duration of MV. Survival for chronic lymphocytic leukemia was 42 percent, for other leukemias 16 percent, Hodgkin's disease 29 percent, and non-Hodgkin's lymphomas, 6 percent. Bronchoscopy was performed in 28 patients, resulting in a diagnosis of infection, hemorrhage, or malignancy in 19 cases. Open lung biopsy (OLB) was obtained in 23 patients, yielding a diagnosis of interstitial inflammation or fibrosis (13 cases), drug effect (three), malignancy (two), hemorrhage (one), Pneumocystis (seven), aspergillosis (two), and Legionella (one). Only two patients survived following OLB. Despite intensive management and adequate diagnosis, respiratory failure in patients with hematologic malignancy carries a high mortality. Although these data may help identify groups with a limited prognosis for long-term recovery, patient care must be individualized.


This article has been cited by other articles:


Home page
 ChestHome page
P. O. Depuydt, D. D. Benoit, K. H. Vandewoude, J. M. Decruyenaere, and F. A. Colardyn
Outcome in Noninvasively and Invasively Ventilated Hematologic Patients With Acute Respiratory Failure
Chest, October 1, 2004; 126(4): 1299 - 1306.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. S. Groeger, P. White Jr, D. M. Nierman, J. Glassman, W. Shi, D. Horak, and K. Price
Outcome for Cancer Patients Requiring Mechanical Ventilation
J. Clin. Oncol., March 1, 1999; 17(3): 991 - 991.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Chest Physicians.